Du forlater nå GSKs nettsider

Denne lenken tar deg til en nettside som ikke tilhører GSK. GSK er ikke ansvarlig for, går ikke god for og aksepterer intet ansvar for informasjon eller meninger på nettsteder til tredjeparter

Fortsett

Tilbake

Videoer - Jemperli

SPOTLIGHT Webinar 2025:

Jemperli + chemo in advanced/recurrent pMMR endometrial cancer patients.

Se video

Introduction to JEMPERLI RUBY Data (dMMR/MSI-H)

Dr. Ilaria Columbo 

Se video

Real-world outcomes in molecular subgroups for patients with advanced or recurrent endometrial cancer treated with platinum-based chemotherapy

Prof. Kristina Lindemann, MD PhD

Se video

Mode of Action

Jemperli i kombinasjon med kjemoterapi

Se video

NA

Patient Case 1

Stage III pMMR/MSS endometrial cancer
Dr.Benoit You
Medical Oncologist
Lyon Unversity Hospital, France

Se video

NA

Patient case 2

Stage lll pMMR endometrial cancer
Patient consideration

Prof. Dr. Klaus Pietzner
Concultant
Charite- University Medicine of Berlin, Germany

Dr. John K.Chan
Director, Gynecologic Oncology
California Pacific Medical
center, San Francisco, USA

Prof.DR. Beynhan Ataseven
Director, Department of Gynecology and Obstetrics
University of Bielefeld/Klinikum Lippe, Germany

Stage III pMMR/MSS endometrial cancer
Dr.Benoit You
Medical Oncologist
Lyon Unversity Hospital, France

Se video

Har du spørsmål om JEMPERLI for dine pasienter? Kontakt oss 

Jemperli trademark is a registered trademark of the GSK group of companies.
© 2025 GSK group of companies or its licensor.